Edition:
United States

Veru Inc (VERU.OQ)

VERU.OQ on NASDAQ Stock Exchange Capital Market

1.32USD
16 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.32
Open
$1.32
Day's High
$1.34
Day's Low
$1.29
Volume
9,657
Avg. Vol
20,213
52-wk High
$2.99
52-wk Low
$0.90

Chart for

About

Veru Inc., formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceut... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $71.71
Shares Outstanding(Mil.): 53.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.03 17.27
EPS (TTM): -- -- --
ROI: -- 14.00 35.43
ROE: -- 15.34 17.10

BRIEF-Veru Q1 Loss Per Share $0.08

* REMAIN ON TRACK TO FILE WITH FDA COMPANY'S FIRST NDA FOR TAMSULOSIN DRS IN 2018

Feb 14 2018

BRIEF-Veru to Present At 2018 Genitourinary Cancers Symposium

* VERU ANNOUNCES PRESENTATION OF DATA DEMONSTRATING EFFICACY OF VERU-111 IN A TAXANE RESISTANT HUMAN PROSTATE CANCER MODEL AT THE 2018 GENITOURINARY CANCERS SYMPOSIUM

Feb 06 2018

BRIEF-Veru reports Q4 Loss Per Share $0.10

* VERU REPORTS FISCAL 2017 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

Jan 02 2018

BRIEF-Veru Inc Files For Non-Timely 10-K

* VERU - DUE TO TECHNICAL DIFFICULTIES AT THIRD PARTY FILING AGENT, CO'S 10-K WAS TRANSMITTED, RECEIVED FOR FILING ON EDGAR AT 5:33 PM ET ON DEC 29, 2017 Source text (http://bit.ly/2EzynHN) Further company coverage:

Jan 02 2018

BRIEF-Veru Acquires Novel Proprietary Formulation For Overactive Bladder

* VERU ACQUIRES NOVEL PROPRIETARY FORMULATION FOR OVERACTIVE BLADDER

Dec 11 2017

BRIEF-Veru announces Tamsulosin drs bioequivalence clinical trial results

* Veru announces Tamsulosin Drs bioequivalence clinical trial results

Nov 13 2017

BRIEF-Veru files for mixed shelf of up to $50 million

* Files for mixed shelf of up to $50 million - SEC filing‍​ Source text: (http://bit.ly/2lfqJfT) Further company coverage:

Oct 25 2017

BRIEF-Veru announces agreement with Timm Medical Technologies to distribute and to promote preboost

* Veru Inc announces agreement with Timm Medical Technologies LLC to distribute and to promote preboost

Oct 03 2017

BRIEF-Veru Inc initiates telemedicine capability to expand access to prescriptions for FC2 female condom

* Veru Inc announces initiation of telemedicine capability to expand access to prescriptions for FC2 female condom Source text for Eikon: Further company coverage:

Sep 26 2017

BRIEF-Ajwan Gulf Real Estate to acquire stake in Health Co and Emaar Food Group

* BOARD APPROVES TO COMPLETE ACQUISITION OF HEALTH CO, ACQUISITION OF 70 PERCENT STAKE IN EMAAR FOOD GROUP

Sep 26 2017

Competitors

Earnings vs. Estimates